Generic Zocor Prompts Some Part D Plans To Make Formulary Adjustments

The largest Medicare Part D sponsors are taking a variety of approaches to Zocor's formulary position following the introduction of a generic version of simvastatin, but they are not going to some of the extremes that non-Medicare commercial plans are

More from Archive

More from Pink Sheet